tenatumomab
inotuzumab
duligotuzumab
tigatuzumab
naptumomab estafenatox
figitumumab
patritumab
drozitumab
acrixolimab
conatumumab
pamrevlumab
oleclumab
panitumumab
lexatumumab
matuzumab
lintuzumab
onartuzumab
adecatumumab
mapatumumab
nofetumomab
dalotuzumab
sibrotuzumab
durvalumab
inotuzumab ozogamicin
oportuzumab monatox
alacizumab
dacetuzumab
amivantamab
teprotumumab
avelumab
agonistic monoclonal antibody
ramucirumab
cixutumumab
apolizumab
ertumaxomab
catumaxomab
cergutuzumab
tabalumab
taplitumomab
samalizumab
milatuzumab
siltuximab
robatumumab
atezolizumab
volociximab
cantuzumab
minretumomab
carlumab
amatuximab
lucatumumab